Chronic renal disease progression: treatment strategies and potassium intake.

[1]  H. Chen,et al.  Hypokalemia Is Associated with Increased Mortality Rate in Chronic Hemodialysis Patients , 2011, Blood Purification.

[2]  R. Mactier,et al.  Renal Association Clinical Practice Guideline on Haemodialysis , 2011, Nephron Clinical Practice.

[3]  M. Tonelli,et al.  The effect of nocturnal and conventional hemodialysis on markers of nutritional status: results from a randomized trial. , 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[4]  M. Burnier,et al.  Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids , 2011, BMC nephrology.

[5]  C. Herzog,et al.  Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. , 2011, Kidney international.

[6]  R. Agarwal,et al.  Should All Hypertensive Dialysis Patients Receive a Blocker of the Renin-Angiotensin System? , 2010, Current hypertension reports.

[7]  Allen R Nissenson,et al.  Dietary potassium intake and mortality in long-term hemodialysis patients. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  G. Cavada,et al.  A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[9]  B. Pitt,et al.  Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[10]  M. Tonelli,et al.  Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[11]  K. Kalantar-Zadeh,et al.  Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[12]  K. Kalantar-Zadeh,et al.  Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[13]  G. Bakris,et al.  Hypokalemia and Outcomes in Patients With Chronic Heart Failure and Chronic Kidney Disease: Findings From Propensity-Matched Studies , 2010, Circulation. Heart failure.

[14]  M. Tonelli,et al.  Dialysate potassium and risk of death in chronic hemodialysis patients. , 2010, Journal of nephrology.

[15]  Y. Toya,et al.  Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis. , 2009, Atherosclerosis.

[16]  L. Appel,et al.  Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy. , 2009, Archives of internal medicine.

[17]  G. Knoll,et al.  Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Peritoneal Dialysis: Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[18]  J. Townend,et al.  Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. , 2009, Journal of the American College of Cardiology.

[19]  R. Sherman,et al.  Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[20]  M. Valsecchi,et al.  Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  M. Zhan,et al.  The frequency of hyperkalemia and its significance in chronic kidney disease. , 2009, Archives of internal medicine.

[22]  S. Kageyama,et al.  Long-Term Low-Dose Spironolactone Therapy Is Safe in Oligoanuric Hemodialysis Patients , 2009, Cardiology.

[23]  S. Navaneethan,et al.  Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[24]  Olivier Moranne,et al.  Timing of onset of CKD-related metabolic complications. , 2009, Journal of the American Society of Nephrology : JASN.

[25]  Tsutomu Inoue,et al.  Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  J. Ingelfinger.  Aliskiren and dual therapy in type 2 diabetes mellitus. , 2008, The New England journal of medicine.

[27]  Takahiko Nakagawa,et al.  Hypokalemic nephropathy is associated with impaired angiogenesis. , 2008, Journal of the American Society of Nephrology : JASN.

[28]  Ping Zhang,et al.  Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7. , 2007, American journal of physiology. Renal physiology.

[29]  S. Greenland,et al.  Serum and dialysate potassium concentrations and survival in hemodialysis patients. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[30]  Raymond Vanholder,et al.  EBPG guideline on nutrition. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  E. Hodson,et al.  Nutrition and growth in kidney disease: CARI guidelines. , 2007, Australian family physician.

[32]  Y. Won,et al.  No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  M. Kiernan,et al.  Uremic neuropathy: Clinical features and new pathophysiological insights , 2007, Muscle & nerve.

[34]  J. Craig,et al.  Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. , 2006, The Cochrane database of systematic reviews.

[35]  F. Zannad,et al.  Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. , 2006, Kidney international.

[36]  Y. Dohi,et al.  Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  A. Zanchetti,et al.  Low glomerular filtration in the population: prevalence, associated disorders, and awareness. , 2006, Kidney international.

[38]  K. Kalantar-Zadeh,et al.  Association of disorders in mineral metabolism with progression of chronic kidney disease. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[39]  N. Powe,et al.  Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  M. Kiernan,et al.  Altered motor nerve excitability in end-stage kidney disease. , 2005, Brain : a journal of neurology.

[41]  B. C. Kwan,et al.  Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  G. Coppolino,et al.  The effect of two different protocols of potassium haemodiafiltration on QT dispersion. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  R Gaggi,et al.  Electrophysiological response to dialysis: the role of dialysate potassium content and profiling. , 2005, Contributions to nephrology.

[44]  B. Kestenbaum,et al.  Serum phosphate levels and mortality risk among people with chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[45]  J. Fink,et al.  Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  G. Braunstein,et al.  Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High-Risk Acute Myocardial Infarction , 2004, Annals of Internal Medicine.

[47]  G. Chertow,et al.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. , 2004, Journal of the American Society of Nephrology : JASN.

[48]  C. Specchia,et al.  The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  M. Ashton,et al.  Safety and Tolerability of High-Dose Angiotensin Receptor Blocker Therapy in Patients with Chronic Kidney Disease: A Pilot Study , 2004, American Journal of Nephrology.

[50]  Bruce Kupelnick,et al.  K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease , 2004 .

[51]  J. Beto,et al.  Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines. , 2004, Journal of the American Dietetic Association.

[52]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[53]  S. Fukuhara,et al.  Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. , 2003, Kidney international.

[54]  W. Owen,et al.  Toward a Continuous Quality Improvement Paradigm for Hemodialysis Providers with Preliminary Suggestions for Clinical Practice Monitoring and Measurement , 2003, Hemodialysis international. International Symposium on Home Hemodialysis.

[55]  A. S. Segal,et al.  Hyperkalemia: An adaptive response in chronic renal insufficiency. , 2002, Kidney international.

[56]  N. Murray,et al.  Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. , 2002, Brain : a journal of neurology.

[57]  C. van Walraven,et al.  Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. , 2002, The American journal of medicine.

[58]  Y. G. Kim,et al.  Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity. , 2001, American journal of physiology. Renal physiology.

[59]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[60]  G. Chertow,et al.  Cardiac arrest and sudden death in dialysis units. , 2001, Kidney international.

[61]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .

[62]  J. Kopple,et al.  National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[63]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[64]  A. Cupisti,et al.  Potassium Removal Increases the QTc Interval Dispersion during Hemodialysis , 1999, Nephron.

[65]  R. Toto,et al.  Efficacy and Tolerability of Losartan in Hypertensive Patients With Renal Impairment , 1998 .

[66]  D. Macpherson,et al.  Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? , 1998, Archives of internal medicine.

[67]  F. Epstein,et al.  On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[68]  C. Wingo,et al.  The effects of potassium depletion and supplementation on blood pressure: a clinical review. , 1997, The American journal of the medical sciences.

[69]  P. Whelton,et al.  Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.

[70]  K. Iseki,et al.  Impact of the initial levels of laboratory variables on survival in chronic dialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[71]  B. Redaelli.  Electrolyte modelling in haemodialysis--potassium. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[72]  R. Agarwal,et al.  Pathophysiology of potassium absorption and secretion by the human intestine , 1994 .

[73]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[74]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[75]  D. Van Dyk,et al.  Causes of death in patients with end-stage renal disease treated by dialysis in a center in Israel. , 1992, Israel journal of medical sciences.

[76]  R. Latini,et al.  Ventricular arrhythmias and four-year mortality in haemodialysis patients , 1992, The Lancet.

[77]  F P Cappuccio,et al.  Does potassium supplementation lower blood pressure? A meta-analysis of published trials. , 1991, Journal of hypertension.

[78]  A. Dyer,et al.  Findings of the International Cooperative INTERSALT Study , 1991, Hypertension.

[79]  Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients. , 1991, Journal of cardiovascular pharmacology.

[80]  E G Lowrie,et al.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[81]  K P Offord,et al.  Association of hypokalemia, aldosteronism, and renal cysts. , 1990, The New England journal of medicine.

[82]  G Block,et al.  Validation of a self-administered diet history questionnaire using multiple diet records. , 1990, Journal of clinical epidemiology.

[83]  R. Prineas,et al.  Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. , 1987, The American journal of cardiology.

[84]  A. Tzamaloukas,et al.  Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis. , 1987, American journal of nephrology.

[85]  J. Stanton,et al.  Blood pressure and nutrient intake in the United States , 1984 .

[86]  M. Shibata,et al.  Clinical study of complications in dialyzed diabetics. , 1983, The Tohoku journal of experimental medicine.

[87]  D. Kem,et al.  Blunted kaliuresis after an acute potassium load in patients with chronic renal failure. , 1983, Kidney international.

[88]  P. Degoulet,et al.  Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. , 1982, Nephron.

[89]  E. Michelson,et al.  Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. , 1980, Kidney international.

[90]  K. Bock,et al.  Symptoms and course of chronic hypokalemic nephropathy in man. , 1977, Clinical nephrology.

[91]  B. B. Johnson,et al.  Aldosterone excretion in normal subjects depleted of sodium and potassium. , 1957, The Journal of clinical investigation.

[92]  W. Schwartz,et al.  The nephropathy of potassium depletion; a clinical and pathological entity. , 1956, The New England journal of medicine.

[93]  J. Darragh,et al.  Potassium and sodium restriction in the normal human. , 1955, The Journal of clinical investigation.